Published in Biomol Ther (Seoul) on March 01, 2017
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA (1998) 32.05
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
Liver regeneration. Hepatology (2006) 7.52
Reliability and reproducibility issues in DNA microarray measurements. Trends Genet (2005) 6.79
Liver regeneration. J Cell Physiol (2007) 6.69
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48
The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res (2012) 5.04
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res (1996) 4.01
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol (1988) 3.54
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49
2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med (2004) 3.29
Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab (2009) 3.29
Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet (1977) 3.00
Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54
Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology (2010) 2.26
Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem (1996) 2.25
Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol (2001) 2.18
Loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity. Proc Natl Acad Sci U S A (2007) 2.02
Review article: drug hepatotoxicity. Aliment Pharmacol Ther (2007) 1.60
TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses. Oncogene (2002) 1.53
Drug-induced liver disease. Med Clin North Am (2000) 1.29
The FDA Acetaminophen Advisory Committee Meeting - what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol (Phila) (2009) 1.10
An integrative genomic analysis identifies Bhmt2 as a diet-dependent genetic factor protecting against acetaminophen-induced liver toxicity. Genome Res (2009) 0.98
Guide for judicious use of the paracetamol absorption technique in a study of gastric emptying rate of liquids. J Gastroenterol (1998) 0.92
Blood gene expression markers to detect and distinguish target organ toxicity. Mol Cell Biochem (2009) 0.92
Gene expression profiles in liver of pigs with extreme high and low levels of androstenone. BMC Vet Res (2008) 0.91
Hepatic GABA(A) receptor functional regulation during rat liver cell proliferation. Hepatol Res (2001) 0.90
Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice. Hepatology (2009) 0.87
Isolation of 10 differentially expressed cDNAs in differentiated Neuro2a cells induced through controlled expression of the GD3 synthase gene. J Neurochem (1999) 0.86
Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure. Toxicol Appl Pharmacol (2009) 0.84
Hepatoprotective effect of aged black garlic extract in rodents. Toxicol Res (2014) 0.83
Differential regulation of mitogen-activated protein kinase pathways by acetaminophen and its nonhepatotoxic regioisomer 3'-hydroxyacetanilide in TAMH cells. Toxicol Sci (2010) 0.83
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle. Front Genet (2012) 0.81
Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen. Hepatology (2001) 0.81
Expression levels of pituitary tumor transforming 1 and glutathione-S-transferase theta 3 are associated with the individual susceptibility to D-galactosamine-induced hepatotoxicity. Toxicol Appl Pharmacol (2009) 0.79
Highly expressed protein kinase A inhibitor α and suppression of protein kinase A may potentiate acetaminophen-induced hepatotoxicity. Toxicol Lett (2014) 0.77
Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats. PLoS One (2015) 0.77
The effect of different doses of flumazenil on acetaminophen toxicity in rats. Bratisl Lek Listy (2012) 0.77
Rab25 Deficiency Perturbs Epidermal Differentiation and Skin Barrier Function in Mice. Biomol Ther (Seoul) (2019) 0.75
Platelet Shape Changes and Cytoskeleton Dynamics as Novel Therapeutic Targets for Anti-Thrombotic Drugs. Biomol Ther (Seoul) (2016) 0.75
Low-Dose Bisphenol A Increases Bile Duct Proliferation in Juvenile Rats: A Possible Evidence for Risk of Liver Cancer in the Exposed Population? Biomol Ther (Seoul) (2017) 0.75
New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism. Biomol Ther (Seoul) (2017) 0.75
A New Murine Liver Fibrosis Model Induced by Polyhexamethylene Guanidine-Phosphate. Biomol Ther (Seoul) (2022) 0.75
Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. Vascul Pharmacol (2016) 0.75